Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Conmed Corp. (NYSE: CNMD) closed at $65.78 in the last session, up 6.27% from day before closing price of $61.90. In other words, the price has increased by $6.27 from its previous closing price. On the day, 1.14 million shares were traded. CNMD stock price reached its highest trading level at $66.25 during the session, while it also had its lowest trading level at $62.0.
Ratios:
We take a closer look at CNMD’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 59.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.31. For the most recent quarter (mrq), Quick Ratio is recorded 1.08 and its Current Ratio is at 2.18. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 1.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on February 01, 2024, Reiterated its Buy rating but revised its target price to $129 from $119 previously.
On May 22, 2023, CL King started tracking the stock assigning a Buy rating and target price of $140.
KeyBanc Capital Markets Upgraded its Sector Weight to Overweight on March 27, 2023, while the target price for the stock was maintained at $124.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 04 ’23 when Peters Stanley W III sold 2,300 shares for $109.93 per share. The transaction valued at 252,833 led to the insider holds 63 shares of the business.
Peters Stanley W III sold 1,200 shares of CNMD for $122,874 on Nov 07 ’23. The President AS and AET now owns 63 shares after completing the transaction at $102.39 per share. On Sep 13 ’23, another insider, Peters Stanley W III, who serves as the President AS and AET of the company, sold 2,000 shares for $107.31 each. As a result, the insider received 214,629 and left with 63 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNMD now has a Market Capitalization of 2026070016 and an Enterprise Value of 2983020032. As of this moment, Conmed’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.19, and their Forward P/E ratio for the next fiscal year is 11.97. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.61 while its Price-to-Book (P/B) ratio in mrq is 2.37. Its current Enterprise Value per Revenue stands at 2.365 whereas that against EBITDA is 14.442.
Stock Price History:
Over the past 52 weeks, CNMD has reached a high of $138.47, while it has fallen to a 52-week low of $61.05. The 50-Day Moving Average of the stock is -16.18%, while the 200-Day Moving Average is calculated to be -33.62%.
Shares Statistics:
According to the various share statistics, CNMD traded on average about 596.83K shares per day over the past 3-months and 912750 shares per day over the past 10 days. A total of 30.77M shares are outstanding, with a floating share count of 30.63M. Insiders hold about 0.79% of the company’s shares, while institutions hold 116.35% stake in the company. Shares short for CNMD as of 1713139200 were 3894480 with a Short Ratio of 6.53, compared to 1710460800 on 3930469. Therefore, it implies a Short% of Shares Outstanding of 3894480 and a Short% of Float of 17.549999.
Dividends & Splits
The forward annual dividend rate for CNMD is 0.80, which was 0.8 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.012924071The stock’s 5-year Average Dividend Yield is 0.79.
